biomea fusion
572 posts
biomea fusion
@biomeafusion
We are creating an entirely new Generation of Precision Medicine against Genetically Defined Diseases.
- WEBCAST 🚨 Biomea Fusion Chairman & CEO Thomas Butler presents our company's activities and progress at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California. 👉 Listen to the webcast - bit.ly/3k8qOAZ #JPMHC23 #JPM23 #healthcare #biotech
- Priyanka Somanath, PhD, Associate Director at Biomea Fusion presents her talk on BMF-219 in animal models of diabetes and the durable improvement in beta-cell function and glycemic control. #WCIRDC23 #TeamFusion #Diabetes #T1D #T2D #WCIRDC #Biomea #BiomeaFusion #BiomeaAtWCIRDC
- A full house at our breakfast symposium pre-opening to the World Congress Insulin Resistance & Cardiovascular Disease! #WCIRDC23 #TeamFusion #Diabetes #T1D #T2D #WCIRDC #Biomea #BiomeaFusion #BiomeaAtWCIRDC #BiomeaBetaCellScience
- 📣 Biomea Fusion Presents Achievement of Minimal Residual Disease Negativity (MRD-neg) in First Complete Responder from Ongoing Phase I Study (COVALENT-101) of BMF-219 in Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) at the 2023 ASH Read more here:
- Today is "Menin Monday" We highlight our clinical investigation of BMF-219 in Type 2 diabetes patients. Check out our fact sheet at bit.ly/3WMHpJX #T2D #Biotech $BMEA #Type2Diabetes #BiotechNews #MedTwitter
- Biomea Fusion is part of the @Nasdaq Biotech Index! This is a huge accomplishment for our company — we're excited to see Biomea recognized on the Nasdaq tower in Times Square. - biomeafusion.com #JPMHC23 #JPM23 #JPM2023 $BMEA #biotech #biotechnews
- Biomea CEO, Thomas Butler, expects to share late-breaking clinical data from COVALENT-111 at the upcoming American Diabetes Association Scientific Sessions in San Diego. Follow us for updates - bit.ly/3VvWi2A #Biotech #T2D #Type2Diabetes #Diabetes #ADA2023 $BMEA
- 📣 Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts Read more here: investors.biomeafusion.com/news-releases/… #Diabetes #DiabetesInnovation #T2D #BiomeaFusion #Biomea #BiomeaBetaCellScience
- We’re 6 weeks out from the #ADA2023. We're counting down to the conference with Menin Mondays: A weekly Q&A on BMF-219 and menin inhibition as a potential breakthrough approach for treating diabetes. bit.ly/3Iy6Clb #ADA2023 #diabetes #T2D #biotech #biotechnews $BMEA
- 📣 Join us at #ADA2023 in San Diego, CA, where we'll unveil additional data from our #diabetes COVALENT-111 clinical trial for our #Type2diabetes (#T2D) investigational drug, BMF-219. 👉 menin.org #BiomeaFusion #MeninProtein $BMEA #Biotech #BiotechNews
- FDA's Dr. Lisa Yanoff emphasizes the urgency for antidiabetic solutions as the agency presents new draft guidelines for diabetes -- Biomea Fusion aims to address a root cause of diabetes with BMF-219. 💊 biomeafusion.com #T2D #biotech #ADA2023 #biotechnews #medicalnews
